Cero Therapeutics Holdings Stock Today
| CEROW Stock | 0.01 0.0008 6.45% |
PerformanceOK
| Odds Of DistressHigh
|
CERo Therapeutics is selling for under 0.0116 as of the 24th of March 2025; that is 6.45 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0115. CERo Therapeutics has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
IPO Date 29th of November 2021 | Category Healthcare |
CERo Therapeutics is entity of United States. It is traded as Stock on NASDAQ exchange. More on CERo Therapeutics Holdings
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
CERo Stock Highlights
| Interim Chairman | Christopher MBA | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
CERo Therapeutics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CERo Therapeutics' financial leverage. It provides some insight into what part of CERo Therapeutics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
CERo Therapeutics Holdings (CEROW) is traded on NASDAQ Exchange in USA. It is located in 201 Haskins Way, South San Francisco, CA, United States, 94080 and employs 8 people. CERo Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification. The company classifies itself under Healthcare sector and is part of Biotechnology industry.
CERo Therapeutics generates negative cash flow from operations
Check CERo Therapeutics Probability Of Bankruptcy
CERo Therapeutics Historical Income Statement
CERo Stock Against Markets
CERo Therapeutics Corporate Executives
Elected by the shareholders, the CERo Therapeutics' board of directors comprises two types of representatives: CERo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CERo. The board's role is to monitor CERo Therapeutics' management team and ensure that shareholders' interests are well served. CERo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CERo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lawrence MD | Cofounder Board | Profile | |
| Charles Carter | Treasurer, CFO | Profile |
Additional Tools for CERo Stock Analysis
When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.